Ongoing research is probing novel applications of GLP-1 agonists beyond diabetes and obesity from potential use in metabolic dysfunction-associated steatohepatitis (MASH) to trials investigating neuroprotective effects in conditions like Parkinsons and Alzheimers disease, though the 2025 phase 3 trials in both conditions failed to show clinical benefit ( [24] ) ( [25] )
[2] Stimulants [edit] A stimulant is defined as an agent (as a drug) that temporarily increases the activity central nervous system and the body
Oral GLP-1 Drops vs Injection, Pros, Cons, and Reality Explained Oral GLP-1 options have generated a lot of buzz because they promise a needle-free path to the same appetite-suppressing benefits as weekly injections
Sarin SK, Sharma M, Koradia P, Duseja A, Bhatia S, Dixit VK, et al
For example, CJC-1295 and Ipamorelin are often stacked for broader growth hormone effects, though the visceral-fat evidence for them is thinner than for tesamorelin